These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38678289)

  • 1. Assessing fragility of statistically significant findings from randomized controlled trials assessing pharmacological therapies for opioid use disorders: a systematic review.
    Naji L; Dennis B; Rodrigues M; Bawor M; Hillmer A; Chawar C; Deck E; Worster A; Paul J; Thabane L; Samaan Z
    Trials; 2024 Apr; 25(1):286. PubMed ID: 38678289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fragility of Statistically Significant Results in Pediatric Orthopaedic Randomized Controlled Trials as Quantified by the Fragility Index: A Systematic Review.
    Khormaee S; Choe J; Ruzbarsky JJ; Agarwal KN; Blanco JS; Doyle SM; Dodwell ER
    J Pediatr Orthop; 2018 Sep; 38(8):e418-e423. PubMed ID: 29979332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fragility of statistically significant findings from randomized trials in spine surgery: a systematic survey.
    Evaniew N; Files C; Smith C; Bhandari M; Ghert M; Walsh M; Devereaux PJ; Guyatt G
    Spine J; 2015 Oct; 15(10):2188-97. PubMed ID: 26072464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria.
    Dennis BB; Roshanov PS; Naji L; Bawor M; Paul J; Plater C; Pare G; Worster A; Varenbut M; Daiter J; Marsh DC; Desai D; Samaan Z; Thabane L
    Trials; 2015 Oct; 16():475. PubMed ID: 26489415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Fragility of Statistically Significant Findings From Randomized Trials in Sports Surgery: A Systematic Survey.
    Khan M; Evaniew N; Gichuru M; Habib A; Ayeni OR; Bedi A; Walsh M; Devereaux PJ; Bhandari M
    Am J Sports Med; 2017 Jul; 45(9):2164-2170. PubMed ID: 27895038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fragility and Reliability of Conclusions of Anesthesia and Critical Care Randomized Trials With Statistically Significant Findings: A Systematic Review.
    Grolleau F; Collins GS; Smarandache A; Pirracchio R; Gakuba C; Boutron I; Busse JW; Devereaux PJ; Le Manach Y
    Crit Care Med; 2019 Mar; 47(3):456-462. PubMed ID: 30394920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Results of Randomized Controlled Trials in Emergency Medicine Are Frequently Fragile.
    Brown J; Lane A; Cooper C; Vassar M
    Ann Emerg Med; 2019 Jun; 73(6):565-576. PubMed ID: 30551894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
    Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006332. PubMed ID: 29869799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fragility of Statistically Significant Findings in Pediatric Critical Care Randomized Controlled Trials.
    Matics TJ; Khan N; Jani P; Kane JM
    Pediatr Crit Care Med; 2019 Jun; 20(6):e258-e262. PubMed ID: 31013262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragility of cardiovascular outcome trials (CVOTs) examining nutrition interventions among patients with diabetes mellitus: a systematic review of randomized controlled trials.
    Taouktsi N; Papageorgiou ST; Tousinas G; Papanikolopoulou S; Grammatikopoulou MG; Giannakoulas G; Goulis DG
    Hormones (Athens); 2022 Dec; 21(4):665-681. PubMed ID: 36129664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder.
    Dennis BB; Sanger N; Bawor M; Naji L; Plater C; Worster A; Woo J; Bhalerao A; Baptist-Mohseni N; Hillmer A; Rice D; Corace K; Hutton B; Tugwell P; Thabane L; Samaan Z
    Trials; 2020 Jan; 21(1):30. PubMed ID: 31907000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses.
    Rice D; Corace K; Wolfe D; Esmaeilisaraji L; Michaud A; Grima A; Austin B; Douma R; Barbeau P; Butler C; Willows M; Poulin PA; Sproule BA; Porath A; Garber G; Taha S; Garner G; Skidmore B; Moher D; Thavorn K; Hutton B
    PLoS One; 2020; 15(12):e0244401. PubMed ID: 33370393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fragility of statistical findings in distal biceps tendon repairs: a systematic review of randomized controlled trials.
    Megafu MN; Mian HS; Hassan MM; Parsons BO; Li X; Parisien RL
    J Shoulder Elbow Surg; 2023 Aug; 32(8):e379-e386. PubMed ID: 37075937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review.
    Fluyau D; Revadigar N; Pierre CG
    Drug Alcohol Depend; 2020 Mar; 208():107845. PubMed ID: 31978670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol.
    Sanger N; Shahid H; Dennis BB; Hudson J; Marsh D; Sanger S; Worster A; Teed R; Rieb L; Tugwell P; Hutton B; Shea B; Beaton D; Corace K; Rice D; Maxwell L; Samaan MC; de Souza RJ; Thabane L; Samaan Z
    BMJ Open; 2018 Dec; 8(12):e025059. PubMed ID: 30518592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are results from randomized trials in anesthesiology robust or fragile? An analysis using the fragility index.
    Goerke K; Parke M; Horn J; Meyer C; Dormire K; White B; Bright T; Walters C; Vassar M
    Int J Evid Based Healthc; 2020 Mar; 18(1):116-124. PubMed ID: 31415254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Continuous Fragility Index of Statistically Significant Findings in Randomized Controlled Trials That Compare Interventions for Anterior Shoulder Instability.
    Al-Asadi M; Sherren M; Abdel Khalik H; Leroux T; Ayeni OR; Madden K; Khan M
    Am J Sports Med; 2024 Aug; 52(10):2667-2675. PubMed ID: 38258495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.
    Adi Y; Juarez-Garcia A; Wang D; Jowett S; Frew E; Day E; Bayliss S; Roberts T; Burls A
    Health Technol Assess; 2007 Feb; 11(6):iii-iv, 1-85. PubMed ID: 17280624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.